Monoclonal Antibody Treatment for COVID-19

MIEMSS_Header_2020_12


 

Please see the attached MIEMSS informational bulletin regarding monoclonal antibody treatment for COVID-19.

 

Recent evidence suggests that many patients who are eligible to receive for this treatment are not receiving it.

 

We believe it is important for all EMS clinicians to have knowledge of this treatment option.

 

Any questions on this bulletin may be referred to infectiousdiseases@miemss.org.